Legal & General Group PLC Recursion Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

$368 Billion
Q4 2024

A detailed history of Legal & General Group PLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 253,426 shares of RXRX stock, worth $1.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

253,426

Previous 199,968 26.73%

Holding current value

$1.67 Million

Previous $1.32 Million 30.07%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$5.7 - $8.27 $304,710 - $442,097	53,458 Added 26.73%	253,426 $1.71 Million
Q3 2024 Feb 28, 2025	SELL	$5.92 - $8.6 $402,281 - $584,395	-67,953 Reduced 26.81%	185,473 $1.22 Million
Q3 2024 Nov 14, 2024	BUY	$5.92 - $8.6 $25,633 - $37,238	4,330 Added 2.21%	199,968 $1.32 Million
Q2 2024 Aug 14, 2024	BUY	$7.35 - $10.05 $322,657 - $441,184	43,899 Added 28.93%	195,638 $1.47 Million
Q1 2024 May 14, 2024	BUY	$9.13 - $15.52 $201,937 - $343,271	22,118 Added 17.06%	151,739 $1.51 Million
Q4 2023 Feb 15, 2024	BUY	$5.09 - $10.79 $58,896 - $124,851	11,571 Added 9.8%	129,621 $1.28 Million
Q3 2023 Nov 14, 2023	BUY	$6.59 - $15.86 $42,604 - $102,534	6,465 Added 5.79%	118,050 $903,000
Q2 2023 Aug 14, 2023	BUY	$4.56 - $9.94 $50,319 - $109,687	11,035 Added 10.97%	111,585 $833,000
Q1 2023 May 15, 2023	BUY	$6.42 - $9.64 $42,243 - $63,431	6,580 Added 7.0%	100,550 $670,000
Q4 2022 Feb 14, 2023	BUY	$7.16 - $12.7 $31,955 - $56,680	4,463 Added 4.99%	93,970 $724,000
Q3 2022 Nov 14, 2022	SELL	$7.83 - $13.6 $178,758 - $310,488	-22,830 Reduced 20.32%	89,507 $952,000
Q2 2022 Aug 22, 2022	BUY	$5.04 - $9.26 $240,150 - $441,229	47,649 Added 73.66%	112,337 $914,000
Q1 2022 May 16, 2022	BUY	$6.16 - $18.03 $270,639 - $792,148	43,935 Added 211.7%	64,688 $463,000
Q4 2021 Feb 14, 2022	BUY	$16.14 - $21.86 $291,278 - $394,507	18,047 Added 666.93%	20,753 $355,000
Q3 2021 Nov 15, 2021	BUY	$19.03 - $41.33 $12,464 - $27,071	655 Added 31.94%	2,706 $62,000
Q2 2021 Aug 12, 2021	BUY	$18.0 - $37.42 $36,918 - $76,748	2,051 New	2,051 $75,000

Others Institutions Holding RXRX

# of Institutions

341

Shares Held

284M

Call Options Held

2.83M

Put Options Held

3.64M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.19B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Recursion Pharmaceuticals, Inc. Transaction History